Percutaneous procedures, without opening the chest, can bring better results than conventional treatment in patients suffering from coronary artery disease and aortic valve stenosis. The results of research conducted by an international team with the participation of Polish researchers have been published in the prestigious journal The Lancet.
The paper in The Lancet concerns transcatheter aortic valve implantation (TAVI) and fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) compared to conventional surgical aortic valve replacement (SAVR) and coronary artery bypass grafting (CABG) in the treatment of patients with aortic valve stenosis and concomitant obstructive coronary artery disease. The research results described in the paper are the result of the work of Polish specialists, including Professor Jerzy Sacha from the Haemodynamic Research Laboratory of the University Hospital in Opole, and experts from abroad.
'The research we have conducted together with colleagues from several European centres is of great practical importance, as it shows that percutaneous procedures (without opening the chest) can bring better results than conventional cardiac surgery in patients suffering from coronary artery disease and aortic valve stenosis. Therefore, we have provided evidence of the effectiveness of minimally invasive methods in the treatment of particularly difficult patients with various concomitant circulatory system diseases. The results of the study will have an impact on future guidelines of scientific societies regarding the treatment of this group of patients. We published the study protocol in the American Heart Journal, and the results in The Lancet', says Professor Jerzy Sacha, who is also a professor at the Faculty of Physical Education and Physiotherapy of the Opole University of Technology.
The authors of the paper in The Lancet also include: Professor Wojciech Wojakowski from the Department of Cardiology and Structural Heart Disease of the Medical University of Silesia in Katowice and Krzysztof Malinowski, PhD, from the Center for Digital Medicine and Robotics, Faculty of Medicine of the Jagiellonian University Medical College.
According to the Scopus database, The Lancet is the best journal in the world out of 636 medical journals. Its Impact Factor is 98.4, which means that papers published in this journal have a huge impact on the development of global medicine. (PAP)
masz/ bar/
